Trial Profile
Retrospective case-series investigating the efficacy outcomes of use of bevacizumab in consecutive infants with Type I retinopathy of prematurity
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Retinopathy of prematurity
- Focus Adverse reactions; Therapeutic Use
- 07 Dec 2015 New trial record